home
contact us
francais
careers
corporate profile
corporate profile
business model
board of directors
officers
locations
investor relations
investor relations
press releases
financial reports
investor presentations
regulatory filings
corporate governance
stock information
events
analyst coverage
investor contact
products
overview
info for patients & healthcare professionals
once-daily tramadol
OLEPTRO
twice-daily tramadol-acetaminophen
twice-daily acetaminophen
abuse-deterrent platform
propofol
SN-38
partners
overview
licensing and distribution partners
research and development partners
current partnerships
partnering contacts
technology
overview
Contramid
®
Polymeric Nano-Delivery System™
media
press releases
events
financial reports
regulatory filings
recent news
2/3/2010
Labopharm Receives FDA Approval For OLEPTRO(TM)
events
TBA
information for:
patients & healthcare professionals
disclaimer
| copyright 2007
